Back
Crinetics Pharmaceuticals Stock Price Chart
Free Stock Analysis Report: See The True Value of Any Stock
Analyze Any Stock Free
Sell
8
CRNX
Crinetics Pharmaceuticals
Last Price:
$40.59
Seasonality Move:
-9.08%
7 Day Trial
ALL ACCESS PASS
$
7
Unlock the power of "two-minute trades"
Learn how today!-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRNX is experiencing slight selling pressure.
Crinetics Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 50.85 | Sell |
| 20-day SMA: | 53.18 | Sell |
| 50-day SMA: | 55.63 | Sell |
| 200-day SMA: | 51.03 | Sell |
| 8-day EMA: | 50.82 | Sell |
| 20-day EMA: | 52.67 | Sell |
| 50-day EMA: | 54.22 | Sell |
| 200-day EMA: | 49.96 | Sell |
Crinetics Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.69 | Sell |
| Relative Strength Index (14 RSI): | 34.32 | Sell |
| Chaikin Money Flow: | -235099 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.1 - 56.94) | Sell |
| Bollinger Bands (100): | (51.5 - 57.46) | Sell |
Crinetics Pharmaceuticals Technical Analysis
| Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Crinetics Pharmaceuticals Stock
Is Crinetics Pharmaceuticals Stock a Buy?
-
Crinetics Pharmaceuticals share price is 48.50 while CRNX 8-day simple moving average is 50.85, which is a Sell signal.
-
The stock price of CRNX is 48.50 while Crinetics Pharmaceuticals 20-day SMA is 53.18, which makes it a Sell.
-
Crinetics Pharmaceuticals 50-day simple moving average is 55.63 while CRNX share price is 48.50, making it a Sell technically.
-
CRNX stock price is 48.50 and Crinetics Pharmaceuticals 200-day simple moving average is 51.03, creating a Sell signal.
CRNX Technical Analysis vs Fundamental Analysis
Sell
8
Crinetics Pharmaceuticals (CRNX)
is a Sell
Is Crinetics Pharmaceuticals a Buy or a Sell?
-
Crinetics Pharmaceuticals stock is rated a SellThe current Crinetics Pharmaceuticals [CRNX] share price is $48.50. The Score for CRNX is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
Crinetics Pharmaceuticals Stock Info
Market Cap:
3.8B
Price in USD:
48.50
Share Volume:
760K
Crinetics Pharmaceuticals 52-Week Range
52-Week High:
62.53
52-Week Low:
35.24
Sell
8
Crinetics Pharmaceuticals (CRNX)
is a Sell
Crinetics Pharmaceuticals Share Price Forecast
-
What is the Crinetics Pharmaceuticals stock price today?The Crinetics Pharmaceuticals stock price is 48.50 USD today.
-
Will CRNX stock go up or go down?Crinetics Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Crinetics Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Crinetics Pharmaceuticals is overvalued.
Is Crinetics Pharmaceuticals Stock a Buy?
-
Crinetics Pharmaceuticals share price is 48.50 while CRNX 8-day exponential moving average is 50.82, which is a Sell signal.
-
The stock price of CRNX is 48.50 while Crinetics Pharmaceuticals 20-day EMA is 52.67, which makes it a Sell.
-
Crinetics Pharmaceuticals 50-day exponential moving average is 54.22 while CRNX share price is 48.50, making it a Sell technically.
-
CRNX stock price is 48.50 and Crinetics Pharmaceuticals 200-day simple moving average is 49.96, creating a Sell signal.
Fundamental Analysis of Crinetics Pharmaceuticals
Is Crinetics Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.47 per share.
Technical Analysis of Crinetics Pharmaceuticals
Should I short Crinetics Pharmaceuticals stock?
-
CRNX Moving Average Covergence Divergence (MACD) indicator is -1.69, suggesting Crinetics Pharmaceuticals is a Sell
-
Crinetics Pharmaceuticals Relative Strength Index (RSI) is 34.32, which suggest Crinetics Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Crinetics Pharmaceuticals is (51.1 - 56.94), which suggest Crinetics Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Crinetics Pharmaceuticals is (51.5 - 57.46), which suggest Crinetics Pharmaceuticals is a Sell
* Crinetics Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.